Zusammenfassung
Es handelt sich hier um eine Vielzahl von Medikamenten, die unterschiedlichen pharmakologischen Stoffgruppen angehören.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Ausgewählte Literatur
Aragon J, Lee MS, Kar S, et al (2005) Percutaneous left ventricular assist device: »TandemHeart« for high-risk coronary intervention. Catheter Cardiovasc Interv 65: 346–352
De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, Brasseur A, Defrance P, Gottignies P, Vincent JL; SOAP II Investigators (2010) Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 362: 779–789
Erdmann E (2009) (Hrsg.) Klinische Kardiologie – Krankheiten des Herzens, des Kreislaufs und der herznahen Gefäße. 7. Aufl., Springer
Ferrari M, Figulla HR (2005) Circulatory assist devices in cardiology. Dtsch Med Wochenschr 130: 652–656
Ferrari M, Poerner TC, Brehm BR, et al (2008) First use of a novel plug-and-play percutaneous circulatory assist device for high-risk coronary angioplasty. Acute Card Care 10: 111–115
Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K, Harjola VP, Mitrovic V, Abdalla M, Sandell EP, Lehtonen L; Steering Committee and Investigators of the Levosimendan Infusion versus Dobutamine (LIDO) Study (2002) Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 360: 196–202
Freitas de Souza C, De Souza Brito F, et al. (2010) Percutaneous Mechanical Assistance for the Failing Heart. J Interven Cardiol 23: 195–202
Garatti A, Colombo T, Russo C, et al (2006) Left ventricular mechanical support with the Impella Recover left direct microaxial blood pump: A single-center experience. Artif Organs 30: 523–528
Gopal S, Jayakumar D, Nelson PN (2009) Meta-analysis on the effect of dopexamine on in-hospital mortality. Anaesthesia 64: 589–594
Holmes CL, Walley KR (2009) Vasoactive drugs for vasodilatory shock in ICU. Curr Opin Crit Care 15: 398–402
Kersten JR et al. (2000) Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of K (ATP) channels. Anesth Analg 90: 5–11
Landoni G, Mizzi A, Biondi-Zoccai G, Bruno G, Bignami E, Corno L, Zambon M, Gerli C, Zangrillo A (2010) Reducing mortality in cardiac surgery with levosimendan: a metaanalysis of randomized controlled trials. J Cardiothorac Vasc Anesth. 24: 51–57
Landoni G, Mizzi A, Biondi-Zoccai G, Bignami E, Prati P, Ajello V, Marino G, Guarracino F, Zangrillo A (2010) Levosimendan reduces mortality in critically ill patients. A meta-analysis of randomized controlled studies. Minerva Anestesiol. 76: 276–286
Lehmann A. et al. (2003) Wirkt Levosimendan bei der operativen Versorgung des akuten Koronarsyndroms inoprotektiv? Anästhesiol Intensivmed Notfallmed Schmerzther 38: 577–582
Moiseyev VS et al. (2002) RUSSLAN Study investigators. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute mycardial infarction. A randomized placebocontrolled double blind study (RUSSLAN). Eur Heart J 23: 1422–1432
Pavie A, Leger P, Nzomvuama A, et al (1998) Left centrifugal pump cardiac assist with transseptal percutaneous left atrial cannula. Artif Organs 22: 502–507
Pulido JN, Park SJ, Rihal CS (2010) Percutaneous Left Ventricular Assist Devices: Clinical Uses, Future Applications, and Anesthetic Considerations. J Cardiothor Vasc Anesth 24: 478–486
Rehberg S, Ertmer C, Van Aken H, Lange M, Broking K, Morelli A, Westphal M (2007) Rolle von Levosimendan in der intensivmedizinischen Behandlung des myokardialen Pumpversagens. Anaesthesist 56: 30–43
Russell JA, Walley KR, Singer J, Gordon AC, Hebert PC, Cooper J, Holmes CL, Mehta S, Granton JT, Storms MM, Cook, DJ, Presneill JJ, Ayers D for the VASST Investigators* (2008) Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock. N Engl J Med 358: 877–888
Salmenperä M, Eriksson H (2009) Levosimendan in perioperative and critical c are patients. Curr Opin Anaesthesiol 22: 496–501
Sjauw KD, Engström AE, Vis MM et al. (2009) A systematic review and meta analysis of intra-aortic pump therapy in ST-elevation myocardial infarction: should we change guidelines? Eur Heart J 30: 459–468
Thiele H, Lauer B, Hambrecht R, et al (2001) Reversal of cardiogenic shock by percutaneous left atrial-to-femoral arterial bypass assistance. Circulation 104: 2917–2922
Thiele H, Smalling RW, Schuler GC (2007) Percutaneous left ventricular assist devices in acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 28: 2057–2063
Trost JC Hillis, LD (2006) Intra-Aortic Balloon Counterpulsation. Am J Cardiol 97: 1391–1398
Vincent JL, Su F (2008) Physiology and pathophysiology of the vasopressinergic system. Best Pract Res Clin Anaesthesiol 22: 243–252
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Fresenius, M., Heck, M. (2011). Kardiovaskulär wirksame Medikamente und mechanische Kreislaufunterstützung. In: Repetitorium Intensivmedizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-16879-6_3
Download citation
DOI: https://doi.org/10.1007/978-3-642-16879-6_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-16878-9
Online ISBN: 978-3-642-16879-6
eBook Packages: Medicine (German Language)